Top-News
Biotechnologie Belgien

Galapagos NV ADR News

Aktie
WKN:  A0YGNJ ISIN:  US36315X1019 US-Symbol:  GLPG
25,20 €
-0,40 €
-1,56%
06.09.24
Handeln Depot/Watchlist
Aktienanzahl *
65,90 Mio.
Marktkapitalisierung *
1,64 Mrd. €
Streubesitz
50,02%
Faktor
1
Originalaktie
BE0003818359
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 17.07.2024

Galapagos NV ADR News

01.08.24 - PR Newswire
BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology
BridGene Biosciences Expands Strategic Collaboration with Galapagos to Develop Selective Oral SMARCA2 PROTAC in Precision Oncology PR Newswire
06.11.23 - PR Newswire
Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-Care
Landmark Bio Signs Multi-​Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-​of-Care PR Newswire
27.01.22 - PR Newswire
Thinking about buying stock in Aridis Pharmaceuticals, Galapagos, Qualtrics, Clean Energy Fuels, or Mattel?
Thinking about buying stock in Aridis Pharmaceuticals, Galapagos, Qualtrics, Clean Energy Fuels, or Mattel? PR Newswire
12.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
03.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
03.03.21 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
10.12.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
10.12.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
23.11.20 - PR Newswire
Selvita to acquire Fidelta from Galapagos
Selvita to acquire Fidelta from Galapagos PR Newswire
19.08.20 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galapagos NV - GLPG PR Newswire
16.04.20 - PR Newswire
Galapagos and Ryvu Announce Research Collaboration
Galapagos and Ryvu Announce Research Collaboration PR Newswire
24.10.18 - PR Newswire
AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program
AbbVie to Assume Full Development and Commercial Control of Cystic Fibrosis Research Program PR Newswire
07.09.16 - The Motley Fool
Die 5 bisher besten Maßnahmen von Gilead Sciences 2016
Gilead Sciences (WKN:885823) scheint den Boden einfach nicht zu finden. Obwohl die Aktie schon jetzt spottbillig mit einem erwarteten Kurs-​Gewinn-Verhältnis von 6,8 ist (das ist ...
14.05.15 - PR Newswire
Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech
Bryan, Garnier & Co Announces the Successful $275m IPO for Galapagos NV, the Largest Nasdaq IPO of European Biotech PR Newswire
24.09.13 - PR Newswire
AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
AbbVie and Galapagos to Co-​Develop Cystic Fibrosis Therapies PR Newswire
17.05.13 - PR Newswire
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease Galapagos to fund ...

Newssuche

Videos

newspaper
04.09.24 -9,76%
Technical Trading: Zucker Long kurzfristig
Sugar Long Typ: Turbo Open End WKN: VV50DP Hebel: 5,06 Laufzeit: OpenEnd Einstieg: Market ... Mehr »